Optimizing Colonoscopy Capacity to Maximize Colorectal Cancer Outcomes
Authors:
- A. Mark FendrickAFA. Mark Fendrick
- Jacob E. KurlanderJKJacob E. Kurlander
- Vahab VahdatVVVahab Vahdat
- Chris EstesCEChris Estes
- Shrey GohilSGShrey Gohil
- Paul J. LimburgPLPaul J. Limburg
- David A. LiebermanDLDavid A. Lieberman
Open Access
- 20 March 2026
- journal article
- Published by Elsevier in Gastro Hep Advances
- Vol. 5 (5)
Abstract
No abstract availableKeywords
Funding Information
- Agency for Healthcare Research and Quality
- National Pharmaceutical Council
- Patient-Centered Outcomes Research Institute
- Arnold Ventures
- U.S. Department of War
- Harvard University
- Centers for Medicare and Medicaid Services
- AbbVie
- Grail
- Genomic Health
- Robert Wood Johnson Foundation
This publication has 35 references indexed in Scilit:
- Estimated Average-Risk Colorectal Cancer Screening–Eligible Population in the USJAMA Network Open, 2024
- Making colonoscopy‐based screening more efficient: A “gateopener” approachInternational Journal of Cancer, 2022
- Utilization of a Colorectal Cancer Screening Test Among Individuals With Average RiskJAMA Network Open, 2021
- Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased MortalityClinical Gastroenterology and Hepatology, 2021
- Screening for Colorectal CancerJAMA, 2021
- Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortalityCancer Medicine, 2019
- Screening for Colorectal CancerJAMA, 2016
- Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacityCancer, 2016
- Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer, 2009
- Natural history of untreated colonic polypsGastroenterology, 1987